Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey

Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany

(2011) Robert Arnou et al.   ADVANCES IN THERAPY

Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina

(2011) Peter Eizenberg et al.   ADVANCES IN THERAPY

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave

(2010) Yiting Xue et al.   BMC PUBLIC HEALTH

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials

(2010) Camille Reygrobellet et al.   Human vaccines & immunotherapeutics

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial

(2010) Robert Arnou et al.   Human vaccines & immunotherapeutics

Seasonal influenza and vaccination coverage

(2010) Arnold S. Monto   VACCINE

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

(2009) Jiri Beran et al.   BMC Medicine

Increasing influenza vaccination coverage in recommended population groups in Europe

(2009) Patricia R Blank et al.   Expert Review of Vaccines

Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study

(2009) Robert Arnou et al.   VACCINE

Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial

(2008) David Holland et al.   JOURNAL OF INFECTIOUS DISEASES

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults

(2008) Isabel Leroux-Roels et al.   VACCINE